InsiderPulse
STEX

STEXStreamex Corp.

SEC ↗
MetricFY2024FY2023FY2022FY2021FY2020FY2019
Service$40K+122.2%$18K
Research and development$832K-83.7%$5.1M-12.5%$5.8M+3.9%$5.6M-69.1%$18.1M+86.2%$9.7M
General and administrative$11.6M-49.6%$23.1M+7.9%$21.4M-23.2%$27.9M-32.0%$41.0M+65.1%$24.8M
Impairment of long term assets$253K
Depreciation and amortization$188K-47.9%$361K+23.2%$293K+48.0%$198K+110.6%$94K+74.1%$54K
Total operating expenses$12.9M-54.8%$28.5M+3.8%$27.5M-18.3%$33.7M-43.1%$59.2M+71.0%$34.6M
Loss from operations-$12.9M+54.9%-$28.5M-4.6%-$27.3M+18.4%-$33.4M+43.5%-$59.2M-71.0%-$34.6M
Interest income (expense), net-$11K-222.2%$9K+200.0%$3K+50.0%$2K-95.6%$45K-66.2%$133K
Gain on settlement and forgiveness of debt$2.5M
Other income (expense), net:$23K+112.3%-$187K
Loss before income taxes-$10.3M+64.0%-$28.7M-5.2%-$27.3M+17.0%-$32.9M+44.4%-$59.1M-71.6%-$34.5M
Income taxes (benefit)$0$0$0
Net loss-$10.3M+64.0%-$28.7M-5.2%-$27.3M+17.0%-$32.9M+44.4%-$59.1M-71.6%-$34.5M
Non-controlling interest$9K+102.6%-$351K-267.1%$210K-77.6%$939K-86.4%$6.9M+1564.5%$416K
Net loss attributable to BioSig Technologies, Inc.-$10.3M+64.4%-$29.0M-7.4%-$27.1M+15.2%-$31.9M+38.9%-$52.2M-53.3%-$34.1M
Preferred stock dividend-$9K+0.0%-$9K+0.0%-$9K+0.0%-$9K+35.7%-$14K+44.0%-$25K
Preferred stock deemed dividend-$174K$0
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS-$10.5M+63.8%-$29.1M-6.5%-$27.3M+14.6%-$31.9M+38.9%-$52.2M-53.3%-$34.1M
Net loss per common share, basic-$750+81.0%-$4K+37.6%-$6K
Net loss per common share, diluted-$750+81.0%-$4K+37.6%-$6K
Weighted average number of common shares outstanding, basic$14.04B+91.0%$7.35B+70.7%$4.31B
Weighted average number of common shares outstanding, diluted$14.04B+91.0%$7.35B+70.7%$4.31B

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.